Wenzel M, Wurnschimmel C, Chierigo F, Tian Z, et al. Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients. Prostate 2021 Jul 26. doi: 10.1002/pros.24202.
PMID: 34312910